Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

INCY.US Logo

INCY.US - Current Price

$103.43

Company Information

▼
Company Name
Incyte Corporation
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US45337C1027
CIK: 0000879169
CUSIP: 45337C102
Currency: USD
Full Time Employees: 2,617
Phone: 302 498 6700
Website: https://www.incyte.com
Fiscal Year End: December
IPO Date: Nov 04, 1993
Description:

Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan. The company offers JAKAFI (ruxolitinib) for the treatment of intermediate or high-risk myelofibrosis, polycythemia vera, and steroid-refractory acute graft-versus-host disease; MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab) for treating relapsed or refractory diffuse large B-cell lymphoma; PEMAZYRE (pemigatinib), a selective fibroblast growth factor receptor kinase inhibitor for the treatment of unresectable biliary tract cancer, metastatic cholangiocarcinoma, and myeloid/lymphoid neoplasms; ICLUSIG (ponatinib), a kinase inhibitor to treat chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia; ZYNYZ (retifanlimab-dlwr) to treat adults with metastatic or recurrent locally advanced Merkel cell carcinoma; and NIKTIMVO (axatilimab-csfr) for treating chronic graft-versus-host disease, as well as OPZELURA (ruxolitinib) cream for treating atopic dermatitis. Its clinical stage products include INCB123667 (CDK2) for ovarian cancer; INCB161734 (KRASG12D) for cancers; INCA33890 (TGFßR2xPD-1) for solid tumors; Ruxolitinib cream for mild to moderate hidradenitis suppurativa (HS); Povorcitinib for HS, nonsegmental vitiligo, prurigo nodularis, and asthma and chronic spontaneous urticaria; INCB000262 (MRGPRX2) and INCB000547 (MRGPRX4) for systemic immune and neuro-immune disorders; INCA034460 (anti-CD122) for vitiligo; and Zilurgisertib (ALK2) for fibrodysplasia ossificans progressive. It has collaboration with Genesis Therapeutics, Inc. The company sells its products to specialty and retail pharmacies, hospital pharmacies, and specialty distributors and wholesalers. The company was formerly known as Incyte Genomics Inc and changed its name to Incyte Corporation in March 2003. Incyte Corporation was incorporated in 1991 and is headquartered in Wilmington, Delaware.

Address:

1801 Augustine Cut-Off, Wilmington, DE, United States, 19803

Directors & Officers

▼
Name Title Year Born
Dr. Pablo J. Cagnoni M.D., Ph.D. President and Head of Research & Development 1963
Dr. Steven H. Stein M.D. Executive VP & Chief Medical Officer 1967
Mr. William Meury CEO, President & Director 1968
Mr. Thomas Tray Principal Financial Officer, VP of Finance & Chief Accounting Officer 1977
Mr. Michael James Morrissey Executive VP & Head of Global Technical Operations 1964
Ms. Alexis Smith Vice President & Head of Investor Relations NA
Mr. Richard A. Hoffman J.D., M.B.A. Executive VP & General Counsel NA
Ms. Pamela M. Murphy Vice President of Investor Relations & Corporate Communications 1951
Ms. Soni K. Basi Ph.D. Executive VP & Chief Human Resources Officer NA
Mr. James H. Lee M.D., Ph.D. Group VP, Head of Inflammation & AutoImmunity Group NA

Shares Statistics

▼
Shares Outstanding: 196.32M
Shares Float: 164.23M
% Insiders: 188.90%
% Institutions: 10,585.90%
Short % Float: 7.57%

Valuation Metrics

▼
Enterprise Value: $17.99B
Trailing P/E: 17.53
Forward P/E: 14.01

Financial Highlights

▼
Market Cap: $20.31B
EBITDA: $1.32B
P/E Ratio: $17.53
PEG Ratio: $0.14
Book Value: $23.72
Earnings/Share: $5.90
Profit Margin: 24.70%
Operating Margin: 31.63%
ROA (TTM): 13.54%
ROE (TTM): 30.39%
Revenue (TTM): $4.81B
Revenue/Share (TTM): $24.79
Earnings Growth (YOY): 290.70%
Revenue Growth (YOY): 20.00%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Dec 31, 2025 0.00 1.93 N/A -10,000.00%
Sep 30, 2025 2.26 1.64 N/A 3,780.49%
Jun 30, 2025 1.57 1.47 N/A 680.27%
Mar 31, 2025 0.80 0.76 N/A 526.32%
Dec 31, 2024 1.43 1.55 N/A -774.19%
Sep 30, 2024 0.54 0.79 N/A -3,164.56%
Jun 30, 2024 -1.82 -1.55 N/A -1,741.94%
Mar 31, 2024 0.64 0.84 N/A -2,380.95%
Dec 31, 2023 1.06 1.16 N/A -862.07%
Sep 30, 2023 1.10 1.02 N/A 784.31%
Jun 30, 2023 0.99 0.83 N/A 1,927.71%
Mar 31, 2023 0.37 0.76 N/A -5,131.58%
Dec 31, 2022 0.62 0.58 N/A 689.66%
Sep 30, 2022 0.60 0.72 N/A -1,666.67%
Jun 30, 2022 1.01 0.76 N/A 3,289.47%
Mar 31, 2022 0.55 0.67 N/A -1,791.04%
Dec 31, 2021 0.10 0.87 N/A -8,850.57%
Sep 30, 2021 1.18 0.75 N/A 5,733.33%
Jun 30, 2021 0.80 0.74 N/A 810.81%
Mar 31, 2021 0.67 0.64 N/A 468.75%
Dec 31, 2020 0.93 0.75 N/A 2,400.00%
Sep 30, 2020 0.23 0.75 N/A -6,933.33%
Jun 30, 2020 1.24 0.87 N/A 4,252.87%
Mar 31, 2020 -2.86 0.61 N/A -56,885.25%
Dec 31, 2019 0.65 0.57 N/A 1,403.51%
Sep 30, 2019 0.82 0.65 N/A 2,615.38%
Jun 30, 2019 0.75 0.48 N/A 5,625.00%
Mar 31, 2019 0.62 0.40 N/A 5,500.00%
Dec 31, 2018 0.40 0.46 N/A -1,304.35%
Sep 30, 2018 0.38 0.40 N/A -500.00%
Jun 30, 2018 0.26 0.34 N/A -2,352.94%
Mar 31, 2018 -0.01 0.04 N/A -12,500.00%
Dec 31, 2017 -0.71 -0.45 N/A -5,777.78%
Sep 30, 2017 0.08 0.07 N/A 1,428.57%
Jun 30, 2017 -0.06 -0.05 N/A -2,000.00%
Mar 31, 2017 -0.68 -1.00 N/A 3,200.00%
Dec 31, 2016 0.05 0.13 N/A -6,153.85%
Sep 30, 2016 0.19 -0.01 N/A 200,000.00%
Jun 30, 2016 0.19 -0.02 N/A 105,000.00%
Mar 31, 2016 0.12 0.17 N/A -2,941.18%
Dec 31, 2015 0.29 0.09 N/A 22,222.22%
Sep 30, 2015 -0.22 -0.41 N/A 4,634.15%
Jun 30, 2015 -0.09 -0.11 N/A 1,818.18%
Mar 31, 2015 -0.11 -0.10 N/A -1,000.00%
Dec 31, 2014 -0.22 -0.09 N/A -14,444.44%
Sep 30, 2014 0.33 0.01 N/A 320,000.00%
Jun 30, 2014 -0.22 -0.04 N/A -45,000.00%
Mar 31, 2014 -0.21 -0.18 N/A -1,666.67%
Dec 31, 2013 -0.15 -0.11 N/A -3,636.36%
Sep 30, 2013 -0.14 -0.13 N/A -769.23%
Jun 30, 2013 0.05 0.08 N/A -3,750.00%
Mar 31, 2013 -0.12 -0.19 N/A 3,684.21%
Dec 31, 2012 0.14 -0.02 N/A 80,000.00%
Sep 30, 2012 -0.17 -0.21 N/A 1,904.76%
Jun 30, 2012 0.03 N/A N/A N/A
Mar 31, 2012 -0.36 -0.46 N/A 2,173.91%
Dec 31, 2011 -0.44 -0.39 N/A -1,282.05%
Sep 30, 2011 -0.42 -0.45 N/A 666.67%
Jun 30, 2011 -0.41 -0.36 N/A -1,388.89%
Mar 31, 2011 -0.21 -0.32 N/A 3,437.50%
Dec 31, 2010 0.24 0.19 N/A 2,631.58%
Sep 30, 2010 -0.26 -0.32 N/A 1,875.00%
Jun 30, 2010 0.02 -0.04 N/A 15,000.00%
Mar 31, 2010 -0.30 -0.32 N/A 625.00%
Dec 31, 2009 -0.41 -0.36 N/A -1,388.89%
Sep 30, 2009 -0.44 -0.40 N/A -1,000.00%
Jun 30, 2009 -0.41 -0.41 N/A 0.00%
Mar 31, 2009 -0.41 -0.41 N/A 0.00%
Dec 31, 2008 -0.50 -0.48 N/A -416.67%
Sep 30, 2008 -0.48 -0.50 N/A 400.00%
Jun 30, 2008 -0.54 -0.50 N/A -800.00%
Mar 31, 2008 -0.47 -0.47 N/A 0.00%
Dec 31, 2007 -0.26 -0.28 N/A 714.29%
Sep 30, 2007 -0.29 -0.27 N/A -740.74%
Jun 30, 2007 -0.22 -0.27 N/A 1,851.85%
Mar 31, 2007 -0.26 -0.26 N/A 0.00%
Dec 31, 2006 -0.24 -0.25 N/A 400.00%
Sep 30, 2006 -0.19 -0.24 N/A 2,083.33%
Jun 30, 2006 -0.24 -0.24 N/A 0.00%
Mar 31, 2006 -0.21 -0.26 N/A 1,923.08%
Dec 31, 2005 -0.33 -0.31 N/A -645.16%
Sep 30, 2005 -0.36 -0.38 N/A 526.32%
Jun 30, 2005 -0.30 -0.33 N/A 909.09%
Mar 31, 2005 -0.24 -0.33 N/A 2,727.27%
Dec 31, 2004 -0.47 -0.35 N/A -3,428.57%
Sep 30, 2004 -0.35 -0.43 N/A 1,860.47%
Jun 30, 2004 -0.87 -0.40 N/A -11,750.00%
Mar 31, 2004 -0.52 -0.45 N/A -1,555.56%
Dec 31, 2003 -0.56 -0.49 N/A -1,428.57%
Sep 30, 2003 -0.60 -0.39 N/A -5,384.62%
Jun 30, 2003 -0.37 -0.39 N/A 512.82%
Mar 31, 2003 -0.36 -0.28 N/A -2,857.14%
Dec 31, 2002 -0.45 -0.39 N/A -1,538.46%
Sep 30, 2002 -0.45 -0.37 N/A -2,162.16%
Jun 30, 2002 -0.26 -0.28 N/A 714.29%
Mar 31, 2002 -0.20 -0.21 N/A 476.19%
Dec 31, 2001 -0.22 -0.76 N/A 7,105.26%
Sep 30, 2001 -0.27 -0.19 N/A -4,210.53%
Jun 30, 2001 -0.15 -0.23 N/A 3,478.26%
Mar 31, 2001 -0.16 -0.28 N/A 4,285.71%
Dec 31, 2000 -0.11 -0.12 N/A 833.33%
Sep 30, 2000 -0.12 -0.12 N/A 0.00%
Jun 30, 2000 -0.10 -0.22 N/A 5,454.55%
Mar 31, 2000 -0.13 -0.28 N/A 5,357.14%
Dec 31, 1999 -0.11 -0.12 N/A 833.33%
Sep 30, 1999 -0.19 -0.19 N/A 0.00%
Jun 30, 1999 -0.11 -0.11 N/A 0.00%
Mar 31, 1999 -0.04 -0.08 N/A 5,000.00%
Dec 31, 1998 0.12 0.10 N/A 2,000.00%
Sep 30, 1998 0.08 0.10 N/A -2,000.00%
Jun 30, 1998 0.10 0.09 N/A 1,111.11%
Mar 31, 1998 0.08 0.08 N/A 0.00%
Dec 31, 1997 0.09 0.07 N/A 2,857.14%
Sep 30, 1997 0.06 0.06 N/A 0.00%
Jun 30, 1997 0.04 0.04 N/A 0.00%
Mar 31, 1997 0.02 0.03 N/A -3,333.33%
Dec 31, 1996 0.01 0.01 N/A 0.00%
Sep 30, 1996 0.00 -0.01 N/A 10,000.00%
Jun 30, 1996 -0.04 -0.03 N/A -3,333.33%
Mar 31, 1996 -0.04 -0.04 N/A 0.00%
Dec 31, 1995 -0.06 -0.06 N/A 0.00%
Sep 30, 1995 -0.09 -0.06 N/A -5,000.00%

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $1.69B $N/A $5.44B $2.00B $3.45B
2023-12-31 $3.21B $N/A $6.78B $1.59B $5.19B
2022-12-31 $2.95B $N/A $5.84B $1.47B $4.37B
2021-12-31 $2.06B $N/A $4.93B $1.16B $3.77B
2020-12-31 $1.51B $N/A $3.56B $949.65M $2.61B
2019-12-31 $1.83B $N/A $3.43B $828.34M $2.60B
2018-12-31 $1.16B $N/A $2.65B $719.80M $1.93B
2017-12-31 $899.51M $N/A $2.30B $671.95M $1.63B
2016-12-31 $652.34M $N/A $1.64B $1.22B $419.47M
2015-12-31 $521.44M $N/A $1.01B $836.29M $171.16M
2014-12-31 $452.30M $N/A $830.07M $878.11M $-81.63M
2013-12-31 $471.43M $N/A $629.57M $822.68M $-193.11M
2012-12-31 $224.06M $N/A $330.42M $505.38M $-174.96M
2011-12-31 $277.59M $N/A $328.96M $556.04M $-227.08M
2010-12-31 $417.91M $N/A $489.58M $578.23M $-88.64M
2009-12-31 $449.82M $N/A $712.39M $814.77M $-102.38M
2008-12-31 $178.77M $N/A $232.39M $453.14M $-220.75M
2007-12-31 $108.85M $N/A $275.70M $435.21M $-159.52M
2006-12-31 $18.86M $N/A $353.60M $438.51M $-84.91M
2005-12-31 $11.49M $N/A $374.11M $393.51M $-19.40M
2004-12-31 $132.18M $N/A $516.92M $438.40M $78.52M
2003-12-31 $29.70M $N/A $379.55M $225.21M $154.33M
2002-12-31 $22.93M $N/A $552.14M $249.73M $302.41M
2001-12-31 $43.37M $N/A $705.56M $265.36M $440.20M
2000-12-31 $110.16M $N/A $886.82M $264.13M $622.69M
1999-12-31 $32.20M $N/A $221.90M $51.60M $170.30M
1998-12-31 $50.00M $N/A $230.30M $50.70M $179.60M
1997-12-31 $51.20M $N/A $193.10M $53.40M $146.00M
1996-12-31 $7.60M $N/A $66.90M $21.70M $45.20M
1995-12-31 $10.40M $N/A $57.80M $11.00M $46.80M
1994-12-31 $6.80M $N/A $28.70M $4.70M $24.00M
1993-12-31 $15.50M $N/A $17.60M $1.50M $16.10M

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Oct 15, 2025 N/A N/A N/A N/A N/A N/A
Sep 16, 2025 N/A N/A N/A N/A N/A N/A
Jul 21, 2025 N/A N/A N/A N/A N/A N/A
Jul 15, 2025 N/A N/A N/A N/A N/A N/A
Jul 15, 2025 N/A N/A N/A N/A N/A N/A
Jul 14, 2025 N/A N/A N/A N/A N/A N/A
Jul 14, 2025 N/A N/A N/A N/A N/A N/A
Jul 03, 2025 N/A N/A N/A N/A N/A N/A
Jul 03, 2025 N/A N/A N/A N/A N/A N/A
Jul 02, 2025 N/A N/A N/A N/A N/A N/A
May 19, 2025 N/A N/A N/A N/A N/A N/A
May 15, 2025 N/A N/A N/A N/A N/A N/A
Mar 14, 2025 N/A N/A N/A N/A N/A N/A
Mar 04, 2025 N/A N/A N/A N/A N/A N/A
Feb 26, 2025 N/A N/A N/A N/A N/A N/A
Jan 21, 2025 N/A N/A N/A N/A N/A N/A
Dec 16, 2024 N/A N/A N/A N/A N/A N/A
Dec 13, 2024 N/A N/A N/A N/A N/A N/A
Nov 29, 2024 N/A N/A N/A N/A N/A N/A
Nov 06, 2024 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist